专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20060039869A1 Intranasal delivery of antipsychotic drugs 审中-公开
标题翻译：鼻内递送抗精神病药
公开(公告)号：US20060039869A1
公开(公告)日：2006-02-23
申请号：US10920153
申请日：2004-08-17
申请人： Daniel Wermeling , Jodi Miller
发明人： Daniel Wermeling , Jodi Miller
IPC分类号： A61K9/14 , A61K31/445 , A61L9/04
CPC分类号： A61K9/0043 , A61K9/08 , A61K31/445
摘要： An intranasal drug product is provided including an antipsychotic drug, such as haloperidol, in sprayable solution in an intranasal metered dose sprayer. Also provided is a method of administering an antipsychotic drug, such as haloperidol, to a patient, including the step of delivering an effective amount of the antipsychotic drug to a patient intranasally using an intranasal metered dose sprayer. A method of treating a psychotic episode also is provided, the method including the step of delivering an antipsychotic drug, such as haloperidol, intranasally in an amount effective to control the psychotic episode.
摘要翻译：提供鼻内药物产品，其包括抗精神病药物，例如氟哌啶醇，在鼻内计量剂量喷雾器中的可喷雾溶液中。还提供了向患者施用抗精神病药物（例如氟哌啶醇）的方法，包括使用鼻内计量剂量喷雾器鼻内递送有效量的抗精神病药物给患者的步骤。还提供了治疗精神病发作的方法，所述方法包括以有效控制精神病发作的量鼻内递送抗精神病药物（例如氟哌啶醇）的步骤。

2. 发明申请

US20070020193A1 Dronabinol compositions and methods for using same 审中-公开
标题翻译：屈高酚组合物及其使用方法
公开(公告)号：US20070020193A1
公开(公告)日：2007-01-25
申请号：US11361463
申请日：2006-02-24
申请人： M. de Vries , Jodi Miller
发明人： M. de Vries , Jodi Miller
IPC分类号： A61L9/04 , A61K31/353
CPC分类号： A61K9/008 , A61K9/0078 , A61K31/352 , A61K31/353
摘要： In various embodiments, the present invention provides pharmaceutical compositions comprising delta-9-THC and to methods of administering such compositions to a patient in need of delta-9-THC therapy.
摘要翻译：在各种实施方案中，本发明提供包含δ-9-THC的药物组合物以及向需要δ-9-THC治疗的患者施用该组合物的方法。

3. 发明授权

US08486925B2 Testosterone gel and method of use 有权
公开(公告)号：US08486925B2
公开(公告)日：2013-07-16
申请号：US13253867
申请日：2011-10-05
申请人： Ramana Malladi , Jodi Miller
发明人： Ramana Malladi , Jodi Miller
IPC分类号： A61K31/56 , A61K31/568 , C07J1/00 , C07C49/00
CPC分类号： A61K9/0014 , A61K9/06 , A61K31/568 , A61K47/10 , A61K47/14 , A61K47/32 , A61P5/26
摘要： The present invention relates to an improved transdermal hydroalcoholic testosterone gel formulation that provides, among other things, a desirable pharmacokinetic hormone profile, and methods of use.

4. 发明授权

US08466138B2 Testosterone gel and method of use 有权
公开(公告)号：US08466138B2
公开(公告)日：2013-06-18
申请号：US13253848
申请日：2011-10-05
申请人： Ramana Malladi , Jodi Miller
发明人： Ramana Malladi , Jodi Miller
IPC分类号： A61K31/56 , A61K31/568 , C07J1/00 , C07C49/00
CPC分类号： A61K9/0014 , A61K9/06 , A61K31/568 , A61K47/10 , A61K47/14 , A61K47/32 , A61P5/26
摘要： The present invention relates to an improved transdermal hydroalcoholic testosterone gel formulation that provides, among other things, a desirable pharmacokinetic hormone profile, and methods of use.

5. 发明申请

US20120028946A1 TESTOSTERONE GEL AND METHOD OF USE 有权
公开(公告)号：US20120028946A1
公开(公告)日：2012-02-02
申请号：US13253848
申请日：2011-10-05
申请人： Ramana Malladi , Jodi Miller
发明人： Ramana Malladi , Jodi Miller
IPC分类号： A61K31/568 , A61P15/08
CPC分类号： A61K9/0014 , A61K9/06 , A61K31/568 , A61K47/10 , A61K47/14 , A61K47/32 , A61P5/26
摘要： The present invention relates to an improved transdermal hydroalcoholic testosterone gel formulation that provides, among other things, a desirable pharmacokinetic hormone profile, and methods of use.

6. 发明授权

US07433829B2 System and method for managing global risk 有权
标题翻译：管理全球风险的制度和方法
公开(公告)号：US07433829B2
公开(公告)日：2008-10-07
申请号：US10012934
申请日：2001-12-10
申请人： Evelyn Borgia , Jodi Miller , Graham De Gottal , Christine O'Connor
发明人： Evelyn Borgia , Jodi Miller , Graham De Gottal , Christine O'Connor
IPC分类号： G06F9/44
CPC分类号： G06Q10/10 , G06Q10/06311 , G06Q10/0639
摘要： A system for tracking compliance to risk management policies for a given enterprise that provides risk status feedback on hierarchical managerial levels. The system notifies users of potential problems with non-compliance of enterprise policies set on a high level of enterprise management, and prompts the users to take steps to achieve compliance. The enterprise policies are designed to protect the enterprise from various forms of risk associated with enterprise activities. Accordingly, minimizing risk across enterprise operations, subdivisions, projects and applications produces an overall benefit of reduced liability or exposure to liability for the entire enterprise. A compliance status is provided by business groups at all levels of the enterprise, and consolidated for each management level to which the risk status is promoted. Higher level managers can view summaries of risk management status for the business divisions, and select particular statuses to view compliance among various business groups under the manager's responsibility.
摘要翻译：用于跟踪针对给定企业的风险管理政策的合规性系统，该风险管理政策为层次管理层面提供风险状态反馈。系统通知用户在企业管理层面设定的企业策略不合规的潜在问题，提示用户采取措施实现合规。企业政策旨在保护企业免受与企业活动相关的各种形式的风险。因此，尽可能减少跨企业运营，细分，项目和应用程序的风险，为整个企业带来减少责任或承担责任的整体利益。合规状态由企业各级企业集团提供，并对风险状态提升的每个管理层进行合并。高级管理人员可以查看业务部门的风险管理状况摘要，并选择特定状态以查看经理责任下各企业集团的合规性。

7. 发明申请

US20120028948A1 TESTOSTERONE GEL AND METHOD OF USE 有权
标题翻译： TESTOSTERONE凝胶和使用方法
公开(公告)号：US20120028948A1
公开(公告)日：2012-02-02
申请号：US13253867
申请日：2011-10-05
申请人： Ramana Malladi , Jodi Miller
发明人： Ramana Malladi , Jodi Miller
IPC分类号： A61K31/568 , A61P5/26
CPC分类号： A61K9/0014 , A61K9/06 , A61K31/568 , A61K47/10 , A61K47/14 , A61K47/32 , A61P5/26
摘要： The present invention relates to an improved transdermal hydroalcoholic testosterone gel formulation that provides, among other things, a desirable pharmacokinetic hormone profile, and methods of use.
摘要翻译：本发明涉及一种改进的透皮水醇睾酮凝胶制剂，其特别提供所需的药代动力学激素分布和使用方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式